Reaction Details Report a problem with these data
Target
Aurora kinase B
Ligand
BDBM560651
Substrate
n/a
Meas. Tech.
Evaluation of Aurora a and Aurora B Inhibitory Effect Kinase Assay
IC50
309±n/a nM
Citation
 Cheng, D; Chen, M; Li, A; Li, H; Yang, G Heterocyclic compounds useful as aurora a selective inhibitors US Patent  US11384066 Publication Date 7/12/2022 
Target
Name:
Aurora kinase B
Synonyms:
AIK2 | AIM-1 | AIM1 | AIRK2 | ARK2 | AURKB | AURKB_HUMAN | Aurora B kinase (aurB) | Aurora B-INCENP | Aurora kinase 2 | Aurora kinase B (AURKB) | Aurora-related kinase 2 | STK-1 | STK1 | STK12 | STK5 | Serine/threonine-protein kinase aurora B
Type:
Protein
Mol. Mass.:
39327.72
Organism:
Homo sapiens (Human)
Description:
Q96GD4
Residue:
344
Sequence:
MAQKENSYPWPYGRQTAPSGLSTLPQRVLRKEPVTPSALVLMSRSNVQPTAAPGQKVMENSSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPMGAQDLISKLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA
  
Inhibitor
Name:
BDBM560651
Synonyms:
(2R,4R)-1-(2,3-dichloro- benzyl)-4-((3-fluoro-4- methyl-6- ((5-methyl-1H-pyrazol-3-yl)- amino)pyridin-2-yl)methyl)-2- methylpiperidine-4-carboxylic acid | US11384066, Example 53
Type:
Small organic molecule
Emp. Form.:
C25H28Cl2FN5O2
Mol. Mass.:
520.427
SMILES:
C[C@@H]1C[C@@](Cc2nc(Nc3cc(C)[nH]n3)cc(C)c2F)(CCN1Cc1cccc(Cl)c1Cl)C(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: